TY - JOUR
AU - Siddiqui, Ruqaiyyah
AU - Khan, Naveed Ahmed
PY - 2020
DA - May
TI - Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19
JO - ACS Chemical Neuroscience
EP - 1524
VL - 11
IS - 11
DO - https://doi.org/10.1021/acschemneuro.0c00288
AB - There is mounting evidence of the central nervous system manifestations associated with COVID-19, particularly in severe cases. Up to 25% of COVID-19 cases exhibit neurological manifestations associated with COVID-19. In view of the devastating nature of the disease due to severe acute respiratory syndrome coronavirus 2, here we debate intranasal drug delivery, in addition to intravenous delivery, as a therapeutic strategy in the management of COVID-19 cases with central nervous system involvement.
PB - ACS Publications
UR - https://researchportal.hw.ac.uk/en/publications/20520210-e7e0-49a5-8201-63d43b63709e
KW - Coronavirus (COVID-19)
ER